Cargando…
Higher prevalence of obesity and overweight without an adverse metabolic profile in girls with central precocious puberty compared to girls with early puberty, regardless of GnRH analogue treatment
OBJECTIVES: 1. To determine BMI, obesity/overweight rates, glucose and lipids at baseline, during GnRHa treatment and shortly after therapy discontinuation in female children with CPP and EP. 2. To compare this response to that seen in a similar group of untreated patients. METHODS: A retrospective...
Autores principales: | Colmenares, Ana, Gunczler, Peter, Lanes, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005618/ https://www.ncbi.nlm.nih.gov/pubmed/24742263 http://dx.doi.org/10.1186/1687-9856-2014-5 |
Ejemplares similares
-
Body mass index in girls with idiopathic central precocious puberty during and after treatment with GnRH analogues
por: Arcari, A. J., et al.
Publicado: (2016) -
Leptin and adiponectin levels in girls with central precocious puberty before and during GnRH agonist treatment
por: Yoo, Jae Won, et al.
Publicado: (2016) -
Evaluating the Efficacy of Treatment with a GnRH Analogue in Patients with Central Precocious Puberty
por: Kendirci, H. Nur Peltek, et al.
Publicado: (2015) -
Serum Anti-Müllerian Hormone Levels in Precocious Puberty Girls according to Stage of GnRH Agonist Treatment
por: Nam, Hyo-Kyoung, et al.
Publicado: (2017) -
Gonadotropin-releasing hormone (GnRH) stimulation test before and after GnRH analogue treatment in central precocious puberty; can GnRH test simplify adequately?
por: Yang, You Jean, et al.
Publicado: (2013)